A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

February 21, 2023

Study Completion Date

February 21, 2023

Conditions
Growth Hormone Deficiency, PediatricEndocrine System DiseasesHormone DeficiencyPituitary Diseases
Interventions
DRUG

TransCon hGH

Once weekly subcutaneous injection of TransCon hGH

Trial Locations (42)

1010

Ascendis Pharma Investigational Site, Auckland

3168

Ascendis Pharma Investigational Site, Clayton

9010

Ascendis Pharma Investigational Site, Varna

10029

Ascendis Pharma Investigational Site, New York

11501

Ascendis Pharma Investigational Site, Mineola

11527

Ascendis Pharma Investigational Site, Athens

22908

Ascendis Pharma Investigational Site, Charlottesville

23507

Ascendis Pharma Investigational Site, Norfolk

32207

Ascendis Pharma Investigational Site, Jacksonville

32308

Ascendis Pharma Investigational Site, Tallahassee

32806

Ascendis Pharma Investigational Site, Orlando

35233

Ascendis Pharma Investigational Site, Birmingham

39216

Ascendis Pharma Investigational Site, Jackson

44195

Ascendis Pharma Investigational Site, Cleveland

55102

Ascendis Pharma Investigational Site, Saint Paul

61093

Ascendis Pharma Investigational Site, Kharkiv

65031

Ascendis Pharma Investigational Site, Odesa

73104

Ascendis Pharma Investigational Site, Oklahoma City

75390

Ascendis Pharma Investigational Site, Dallas

76104

Ascendis Pharma Investigational Site, Fort Worth

80112

Ascendis Pharma Investigational Site, Centennial

90048

Ascendis Pharma Investigational Site, Los Angeles

92868

Ascendis Pharma Investigational Site, Orange

95821

Ascendis Pharma Investigational Site, Sacramento

97227

Ascendis Pharma Investigational Site, Portland

97239

Ascendis Pharma Investigational Site, Portland

98405

Ascendis Pharma Investigational Site, Tacoma

117036

Ascendis Pharma Investigational Site, Moscow

160022

Ascendis Pharma Investigational Site, Vologda

194100

Ascendis Pharma Investigational Site, Saint Petersburg

220020

Ascendis Pharma Investigational Site, Minsk

394024

Ascendis Pharma Investigational Site, Voronezh

410054

Ascendis Pharma Investigational Site, Saratov

426009

Ascendis Pharma Investigational Site, Izhevsk

450008

Ascendis Pharma Investigational Site, Ufa

660022

Ascendis Pharma Investigational Site, Krasnoyarsk

03756

Ascendis Pharma Investigational Site, Lebanon

0075

Ascendis Pharma Investigational Site, Yerevan

0159

Ascendis Pharma Investigational Site, Tbilisi

80-952

Ascendis Pharma Investigational Site, Gdansk

02-691

Ascendis Pharma Investigational Site, Warsaw

01021

Ascendis Pharma Investigational Site, Kyiv

Sponsors
All Listed Sponsors
lead

Ascendis Pharma A/S

INDUSTRY